Open-Label Hepatic Impairment Study

Completed · Phase 1

Conditions studied: Hepatitis C

In brief

This study will be conducted in Hepatitis C positive patients to determine whether the pharmacodynamic effects of PSI-7977 or PSI-352938 are similar to HCV-infected patients with normal hepatic function, which may allow inclusion of patients with cirrhosis and varying degrees of hepatic dysfunction in future clinical studies.

Key facts

Study ID
NCT01497327
Run by
Gilead Sciences
People needed
24
Starts
2011-07-01
Expected to finish
2012-01-01
Last updated by the study team
2012-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.